| Pharmaceutical Information |
| Drug Name |
Cysteine hydrochloride |
| Drug ID |
BADD_D00559 |
| Description |
A thiol-containing non-essential amino acid that is oxidized to form cystine. |
| Indications and Usage |
For the prevention of liver damage and kidney damage associated with overdoses of acetaminophen |
| Marketing Status |
Discontinued |
| ATC Code |
Not Available |
| DrugBank ID |
DB00151
|
| KEGG ID |
D02326
|
| MeSH ID |
D003545
|
| PubChem ID |
25150
|
| TTD Drug ID |
D0P0QK
|
| NDC Product Code |
51754-1007 |
| Synonyms |
Cysteine | L-Cysteine | L Cysteine | Half-Cystine | Half Cystine | Zinc Cysteinate | Cysteine Hydrochloride |
|
| Chemical Information |
| Molecular Formula |
C3H8ClNO2S |
| CAS Registry Number |
10318-18-0 |
| SMILES |
C(C(C(=O)O)N)S.Cl |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Erythema | 23.03.06.001 | - | - | Not Available | | Feeling hot | 08.01.09.009 | - | - | Not Available | | Flushing | 24.03.01.002; 23.06.05.003; 08.01.03.025 | - | - | | | Nausea | 07.01.07.001 | - | - | | | Pyrexia | 08.05.02.003 | - | - | | | Thrombosis | 24.01.01.006 | - | - | Not Available | | Infusion site phlebitis | 08.02.05.003; 24.05.03.002; 12.07.05.004 | - | - | Not Available |
|
The 1th Page
1
Total 1 Pages
|
|
